Katharinenhospital Stuttgart

Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival (2018) Bach C, Heinemann FM, Horn PA, Ziemann M, Lachmann N, Muehlbacher A, Dick A, et al. Journal article Endoscopic approach-routes in the posterior fossa cisterns through the retrosigmoid keyhole craniotomy: an anatomical study (2017) Kurucz P, Baksa G, Patonay L, Thaher F, Buchfelder M, Ganslandt O Journal article Interim results from PAZOREAL: A non-interventional study to assess effectiveness and safety of pazopanib and everolimus in the changing mRCC treatment landscape (2017) Bedke J, Welslau M, Boegemann M, Schostak M, Hering-Schubert C, Petzoldt A, Wolf T, et al. Conference contribution COMBINED ALTERATIONS IN MAPK PATHWAY GENES, CDKN2A/B AND ATRX CHARACTERIZE ANAPLASTIC PILOCYTIC ASTROCYTOMA (2016) Kratz A, Sahm F, Schrimpf D, Jones DT, Reuss D, Koelsche C, Huang K, et al. Conference contribution Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial) (2016) Hecht M, Hahn D, Beutner D, Reichert D, Goehler T, Wurm R, Welslau M, et al. Conference contribution RFA-cut: Semi-automatic segmentation of radiofrequency ablation zones with and without needles via optimal s-t-cuts (2015) Egger J, Busse H, Brandmaier P, Seider D, Gawlitza M, Strocka S, Voglreiter P, et al. Conference contribution Interactive Volumetry of Liver Ablation Zones (2015) Egger J, Busse H, Brandmaier P, Seider D, Gawlitza M, Strocka S, Voglreiter P, et al. Journal article Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial (2015) Behringer K, Goergen H, Hitz F, Zijlstra JM, Greil R, Markova J, Sasse S, et al. Journal article Incidence of bleeding in 8172 percutaneous ultrasound-guided intraabdominal diagnostic and therapeutic interventions - results of the prospective multicenter DEGUM interventional ultrasound study (PIUS study) (2015) Strobel D, Bernatik T, Blank W, Will U, Reichel A, Wuestner M, Keim V, et al. Journal article Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial (2010) Witzel I, Loibl S, Von Minckwitz G, Mundhenke C, Huober J, Hanusch C, Henschen S, et al. Journal article